Calavo ponders buyout as CEO retires
Santa Paula-based Calavo Growers announced that Lee Cole will retire as president and CEO on Dec. 8 — his second retirement in five years — as the company ponders an unsolicited proposal. Announced Nov. 12, this was Cole’s second stint as CEO, as his first go-round was from 1999 until 2020, and he also served as Read More →
Calavo announces CEO succession plans
Santa Paula-based Calavo Growers announced that Lee Cole will retire as president and CEO on Dec. 8, and has appointed John Lindeman, a member of Calavo’s Board of Directors and former Calavo CFO, to succeed him. This was Cole’s second stint as CEO, as his first go-round was from 1999 until 2020, and he also Read More →
Earnings roundup
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Sable’s stock sinks to all-time lows
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
TTD reports strong Q3 to stabilize stock
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
AppFolio shares recover after big selloff from earnings miss
This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen delivers earnings beat in Q3
Thousand Oaks-based Amgen delivered a sound third-quarter earnings beat when it announced financial results on Nov. 4, highlighting big sales beats from blockbuster drugs Repatha and Prolia. Amgen, one of the largest biotechnology companies in the world, announced that revenue for the quarter ended Sept. 30 reached $9.6 billion, a 12% year-over-year increase, driven by Read More →
